478 related articles for article (PubMed ID: 30902669)
21. The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study.
Spinazzola E; Quattrone D; Rodriguez V; Trotta G; Alameda L; Tripoli G; Gayer-Anderson C; Freeman TP; Johnson EC; Jongsma HE; Stilo S; La Cascia C; Ferraro L; La Barbera D; Lasalvia A; Tosato S; Tarricone I; D'Andrea G; Galatolo M; Tortelli A; Tagliabue I; Turco M; Pompili M; Selten JP; de Haan L; Rossi Menezes P; Del Ben CM; Santos JL; Arrojo M; Bobes J; Sanjuán J; Bernardo M; Arango C; Kirkbride JB; Jones PB; O'Donovan M; Rutten BP; Van Os J; Morgan C; Sham PC; Austin-Zimmerman I; Li Z; Vassos E; ; Murray RM; Di Forti M
Psychol Med; 2023 Nov; 53(15):7418-7427. PubMed ID: 37129249
[TBL] [Abstract][Full Text] [Related]
22. Age-varying effects of cannabis use frequency and disorder on symptoms of psychosis, depression and anxiety in adolescents and adults.
Leadbeater BJ; Ames ME; Linden-Carmichael AN
Addiction; 2019 Feb; 114(2):278-293. PubMed ID: 30276906
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for the onset of dependence and chronic psychosis due to cannabis use: Survey of patients with cannabis-related psychiatric disorders.
Matsumoto T; Kawabata T; Okita K; Tanibuchi Y; Funada D; Murakami M; Usami T; Yokoyama R; Naruse N; Aikawa Y; Furukawa A; Komatsuzaki C; Hashimoto N; Fujita O; Umemoto A; Kagaya A; Shimane T
Neuropsychopharmacol Rep; 2020 Dec; 40(4):332-341. PubMed ID: 32896111
[TBL] [Abstract][Full Text] [Related]
24. The impact of cannabis use on age of onset and clinical characteristics in first-episode psychotic patients. Data from the Psychosis Incident Cohort Outcome Study (PICOS).
Tosato S; Lasalvia A; Bonetto C; Mazzoncini R; Cristofalo D; De Santi K; Bertani M; Bissoli S; Lazzarotto L; Marrella G; Lamonaca D; Riolo R; Gardellin F; Urbani A; Tansella M; Ruggeri M;
J Psychiatr Res; 2013 Apr; 47(4):438-44. PubMed ID: 23290558
[TBL] [Abstract][Full Text] [Related]
25. Annual incidence of cannabis-induced psychosis, other substance-induced psychoses and dually diagnosed schizophrenia and cannabis use disorder in Denmark from 1994 to 2016.
Hjorthøj C; Larsen MO; Starzer MSK; Nordentoft M
Psychol Med; 2021 Mar; 51(4):617-622. PubMed ID: 31839011
[TBL] [Abstract][Full Text] [Related]
26. Association of Combined Patterns of Tobacco and Cannabis Use in Adolescence With Psychotic Experiences.
Jones HJ; Gage SH; Heron J; Hickman M; Lewis G; Munafò MR; Zammit S
JAMA Psychiatry; 2018 Mar; 75(3):240-246. PubMed ID: 29344610
[TBL] [Abstract][Full Text] [Related]
27. Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms.
Machielsen M; van der Sluis S; de Haan L
Aust N Z J Psychiatry; 2010 Aug; 44(8):721-8. PubMed ID: 20636193
[TBL] [Abstract][Full Text] [Related]
28. Association Between Continued Cannabis Use and Risk of Relapse in First-Episode Psychosis: A Quasi-Experimental Investigation Within an Observational Study.
Schoeler T; Petros N; Di Forti M; Pingault JB; Klamerus E; Foglia E; Small A; Murray R; Bhattacharyya S
JAMA Psychiatry; 2016 Nov; 73(11):1173-1179. PubMed ID: 27680429
[TBL] [Abstract][Full Text] [Related]
29. Influence of cannabis use on incidence of psychosis in people at clinical high risk.
Chester LA; Valmaggia LR; Kempton MJ; Chesney E; Oliver D; Hedges EP; Klatsa E; Stahl D; van der Gaag M; de Haan L; Nelson B; McGorry P; Amminger GP; Riecher-Rössler A; Studerus E; Bressan R; Barrantes-Vidal N; Krebs MO; Glenthøj B; Nordentoft M; Ruhrmann S; Sachs G; McGuire P;
Psychiatry Clin Neurosci; 2023 Sep; 77(9):469-477. PubMed ID: 37070555
[TBL] [Abstract][Full Text] [Related]
30. Assessing evidence supporting cannabis harm reduction practices for adolescents at clinical high-risk for psychosis: a review and clinical implementation tool.
Kapler S; Adery L; Hoftman GD; Amir CM; Grigoryan V; Cooper ZD; Bearden CE
Psychol Med; 2024 Jan; 54(2):245-255. PubMed ID: 37882050
[TBL] [Abstract][Full Text] [Related]
31. Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: results from the EU-GEI case-control study.
Trotta G; Rodriguez V; Quattrone D; Spinazzola E; Tripoli G; Gayer-Anderson C; Freeman TP; Jongsma HE; Sideli L; Aas M; Stilo SA; La Cascia C; Ferraro L; La Barbera D; Lasalvia A; Tosato S; Tarricone I; D'Andrea G; Tortelli A; Schürhoff F; Szöke A; Pignon B; Selten JP; Velthorst E; de Haan L; Llorca PM; Rossi Menezes P; Del Ben CM; Santos JL; Arrojo M; Bobes J; Sanjuán J; Bernardo M; Arango C; Kirkbride JB; Jones PB; Richards A; Rutten BP; Van Os J; Austin-Zimmerman I; Li Z; Morgan C; Sham PC; Vassos E; Wong C; Bentall R; Fisher HL; Murray RM; Alameda L; Di Forti M;
Psychol Med; 2023 Nov; 53(15):7375-7384. PubMed ID: 38078747
[TBL] [Abstract][Full Text] [Related]
32. Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.
Auther AM; McLaughlin D; Carrión RE; Nagachandran P; Correll CU; Cornblatt BA
Psychol Med; 2012 Dec; 42(12):2485-97. PubMed ID: 22716931
[TBL] [Abstract][Full Text] [Related]
33. Structured lifestyle education for people with schizophrenia, schizoaffective disorder and first-episode psychosis (STEPWISE): randomised controlled trial.
Holt RIG; Gossage-Worrall R; Hind D; Bradburn MJ; McCrone P; Morris T; Edwardson C; Barnard K; Carey ME; Davies MJ; Dickens CM; Doherty Y; Etherington A; French P; Gaughran F; Greenwood KE; Kalidindi S; Khunti K; Laugharne R; Pendlebury J; Rathod S; Saxon D; Shiers D; Siddiqi N; Swaby EA; Waller G; Wright S
Br J Psychiatry; 2019 Feb; 214(2):63-73. PubMed ID: 30251622
[TBL] [Abstract][Full Text] [Related]
34. Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases.
Arendt M; Rosenberg R; Foldager L; Perto G; Munk-Jørgensen P
Br J Psychiatry; 2005 Dec; 187():510-5. PubMed ID: 16319402
[TBL] [Abstract][Full Text] [Related]
35. The Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study.
Brink V; Andleeb H; Gayer-Anderson C; Arango C; Arrojo M; Berardi D; Bernardo M; Bobes J; Del-Ben CM; Ferraro L; de Haan L; La Barbera D; La Cascia C; Lasalvia A; Llorca PM; Menezes PR; Pignon B; Sanjuán J; Santos JL; Selten JP; Tarricone I; Tortelli A; Tripoli G; Velthorst E; Rutten BPF; van Os J; Quattrone D; Murray RM; Jones PB; Morgan C; Di Forti M; Jongsma HE; Kirkbride JB
Schizophr Bull; 2024 May; ():. PubMed ID: 38788048
[TBL] [Abstract][Full Text] [Related]
36. [Motivational interviewing for cannabis users with psychotic disorders].
Bonsack C; Montagrin Y; Favrod J; Gibellini S; Conus P
Encephale; 2007 Oct; 33(5):819-26. PubMed ID: 18357854
[TBL] [Abstract][Full Text] [Related]
37. Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study.
Kuepper R; van Os J; Lieb R; Wittchen HU; Höfler M; Henquet C
BMJ; 2011 Mar; 342():d738. PubMed ID: 21363868
[TBL] [Abstract][Full Text] [Related]
38. Differential effects of sex on substance use between first episode psychosis patients and healthy people.
Núñez C; Ochoa S; Huerta-Ramos E; Baños I; Barajas A; Dolz M; Sánchez B; Del Cacho N; ; Usall J
Compr Psychiatry; 2016 Aug; 69():169-78. PubMed ID: 27423358
[TBL] [Abstract][Full Text] [Related]
39. IQ differences between patients with first episode psychosis in London and Palermo reflect differences in patterns of cannabis use.
Ferraro L; Murray RM; Di Forti M; Quattrone D; Tripoli G; Sideli L; La Barbera D; La Cascia C
Schizophr Res; 2019 Aug; 210():81-88. PubMed ID: 31272907
[TBL] [Abstract][Full Text] [Related]
40. Cannabis use and psychosis: a longitudinal population-based study.
van Os J; Bak M; Hanssen M; Bijl RV; de Graaf R; Verdoux H
Am J Epidemiol; 2002 Aug; 156(4):319-27. PubMed ID: 12181101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
